HNB
CLVS

Huntington National Bank’s Clovis Oncology, Inc. CLVS Stock Holding History

Huntington National Bank’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-800
Closed -$1K – 2521
2022
Q2 		$1K Buy
+800
New +$1.18K ﹤0.01% 1996
2015
Q4 		– Sell
-9
Closed – – 1721
2015
Q3 		$0 Buy
+9
New +$779 ﹤0.01% 1811

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Huntington National Bank's CLVS Position: Q3 2022 in Review

Huntington National Bank sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 800 shares — an estimated $1K sold.

Huntington National Bank first reported a position in CLVS in Q3 2015 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Huntington National Bank reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Huntington National Bank sold 800 Clovis Oncology, Inc. shares in Q3 2022, an estimated $1K.
  • Huntington National Bank first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 2 quarters.
  • Huntington National Bank's Clovis Oncology, Inc. position peaked at $1K in Q2 2022.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Huntington National Bank's 13F filing for Q3 2022, filed 7 Nov 2022.